Eric Lefkofsky – Life and Business

Mr. Eric Lefkofsky is from Southfield, Michigan. He achieved his higher education at the University of Michigan based in Ann Arbor. Mr. Eric Lefkofsky obtained a Juris Doctor from the School of Law of the same university and even though he could have directed his career into Law, Mr. Eric Lefkofsky went into business. He has said that his change of direction was largely due to the dot-com crash and he decided to go with his gut feeling because he believed he had a solution that could make him successful.

As it turned out, Mr. Eric Lefkofsky was right about his feeling, and he was a power player in the crash. Later on, Mr. Eric Lefkofsky started sporting quite the portfolio full of his series of founded and co-founded businesses working in industries such as e-commerce, biotechnology, marketing, logistics and analytics, telecommunication, and more.

During his career, Eric Lefkofsky has also contributed to the education sector through his teaching positions. He worked at the DePaul University- Kellstadt Graduate School of Business as well as at the Kellogg School of Management owned by the Northwestern University. Now, Mr. Eric Lefkofsky is an adjunct professor at the Booth School of Business held by the Universty of Chicago.

Mr. Eric Paul Lefkofsky is most known as the co-founder and Chief Executive Officer of Tempus. Tempus was founded in 2015 with the goal to aid the development of cancer treatments by providing a platform that collects, stores, and analyses medical data and molecular data. Creating a platform to globalize the access to medical data allows it to be used more efficiently by doctors working on treatments for cancer as well as to create more personalized treatments for their patients. Mr. Eric Lefkofsky first got the idea to create this data sharing platform and co-found the Tempus company after a loved one was diagnosed with breast cancer. Eric Lefkofsky realized the medical field lacked a platform that digitally collected and shared data to be used for treatment research and that made it ineffective and incapable to create better therapy treatments for cancer patients.

February 2, 2018

Posted In: Business success, Finance Industry

Tags: